- Research works
- 38 ▼ 23% vs 2013–17
- Citations
- 449 11.9 per fractional work
- Top-10% rate
- 7.3% record average 16.5%
- Open access
- 54% world 28%
Not ranked overall: Meiji Pharma Spain is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Health Professions, 3.8×. Every wedge is a field page.
Which keywords describe research at Meiji Pharma Spain?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Antimicrobial Resistance, Clinical Practice Guidelines, Community-Acquired Pneumonia, Pneumococcal Conjugate Vaccine, Inflammation, Antibiotic Pharmacokinetics and Critically Ill Patients.
- Residential
- Virulence Factors
- Paleoclimatology
- Glacial Cycles
- ESKAPE Pathogens
- Hazard
- Clinical Management
- Antibiotic Resistance
- Remote Sensing
- Critically Ill Patients
- Antibiotic Pharmacokinetics
- Pneumococcal Conjugate Vaccine
- Inflammation
- Antimicrobial Resistance
- Epidemiology
- Clinical Practice Guidelines
- Community-Acquired Pneumonia
- Oxidative Stress
- Climate Change
- Nutrition
- Risk Assessment
- GIS-based Modeling
- Pathogenesis
- Landslide
- Multidrug-Resistant Bacteria
- Obesity
- Regeneration
- Aging
- Segregation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 29 words, with their numbers
- Epidemiology9▲ 5.8×16 topics
- Antimicrobial Resistance6▲ 68×5 topics
- Clinical Practice Guidelines4▲ 17×5 topics
- Inflammation3▲ 3.8×14 topics
- Community-Acquired Pneumonia3▲ 189×1 topic
- Pneumococcal Conjugate Vaccine3▲ 189×1 topic
- Oxidative Stress3▲ 4.0×12 topics
- Antibiotic Pharmacokinetics2▲ 138×1 topic
- Climate Change2▲ 2.3×7 topics
- Critically Ill Patients2▲ 138×1 topic
- Nutrition2▲ 11×5 topics
- Remote Sensing2▲ 4.2×2 topics
- Risk Assessment2▲ 7.5×3 topics
- Antibiotic Resistance2▲ 11×2 topics
- GIS-based Modeling2▲ 53×2 topics
- Clinical Management1▲ 19×2 topics
- Pathogenesis1▲ 6.7×3 topics
- Hazard1▲ 64×1 topic
- Landslide1▲ 64×1 topic
- ESKAPE Pathogens1▲ 60×1 topic
- Multidrug-Resistant Bacteria1▲ 60×1 topic
- Glacial Cycles1▲ 26×1 topic
- Obesity1▲ 3.9×5 topics
- Paleoclimatology1▲ 22×1 topic
- Regeneration1▲ 17×2 topics
- Virulence Factors1▲ 16×3 topics
- Aging1▲ 5.2×3 topics
- Residential1▲ 159×1 topic
- Segregation1▲ 34×1 topic
Which research topics does Meiji Pharma Spain publish most on?
By volume in 2022–2025: Sleep and related disorders, Health and Lifestyle Studies, Osteoarthritis Treatment and Mechanisms and Antimicrobial Resistance in Staphylococcus.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Sleep and related disorders Experimental and Cognitive Psychology 0 works
- 2 Health and Lifestyle Studies General Health Professions 0 works
- 3 Osteoarthritis Treatment and Mechanisms Rheumatology 0 works
- 4 Antimicrobial Resistance in Staphylococcus Infectious Diseases 0 works
- 5 Total Knee Arthroplasty Outcomes Surgery 0 works
- 6 Pneumonia and Respiratory Infections Epidemiology 0 works
- 7 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
- 8 Proteoglycans and glycosaminoglycans research Cell Biology 0 works
- 9 Iron Metabolism and Disorders Hematology 0 works
- 10 Diabetic Foot Ulcer Assessment and Management Endocrinology, Diabetes and Metabolism 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Meiji Pharma Spain's research output changed?
Output in 2018–2022 was 23% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Alcalá de Henares
- Universidad Complutense de Madrid
- Universidad Autónoma de Madrid
- Universidad Politécnica de Madrid
- Consejo Superior de Investigaciones Científicas
- Universidad Carlos III de Madrid
- Universidad Rey Juan Carlos
- Universidad Nacional de Educación a Distancia
- Hospital Universitario La Paz
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.